T he revolutionary introduction of invasive coronary angiography (CAG) in 1959 (1) and elucidation of the relationship between anatomical stenosis severity and hyperemic flow (2) dramatically improved our understanding of coronary artery disease (CAD). Since then, anatomical stenosis severity has been used as an indicator for percutaneous coronary intervention (PCI). However, anatomical assessment of CAD is substantially variable among observers (3) and angiographically guided PCI did not always improve outcome in patients with stable CAD (4, 5) . Moreover, better prognosis of fractional flow reserve (FFR)-guided PCI was reported in two landmark clinical trials (6, 7) . In consequence, functional significance is considered as clinically more relevant than is anatomical stenosis severity for the treatment decision in stable CAD.
Myocardial perfusion positron emission tomography (PET)
has long been regarded as a reliable tool for measurement of myocardial blood flow (MBF). Apparently, however, FFR has several advantages over PET-measured MBF, such as less dependence on hemodynamic changes, simplicity, relatively discrete and clear cutoff, lesion-specificity, and robust prognostic gain from FFR-guided PCI (8) (9) (10) . As a result, despite that pressure cannot fully substitute flow, the current gold standard of functionally significant CAD is undoubtedly FFR. In this article, the challenges, strengths, and possible breakthrough of MBF measurement by myocardial perfusion PET are discussed from the perspectives of nuclear cardiology practitioners in so-called "the era of FFR".
Definition and development of FFR
FFR is a fraction of the maximal achievable flow in the stenosed artery divided by the maximal achievable flow if the artery were to be normal (10, 11) . According to Ohm's law, flow is derived by dividing pressure with resistance. The induction of maximal hyperemia decreases microvascular resistance nearly zero, making the denominator negligible. In addition, the venous pressure is also negligible in comparison
The FFR cutoff ≤ 0. 75 was associated with inducible ischemia evidenced by stress testing (13) . It was applied to the decision of deferral of PCI in the DEFER study (14) showing excellent prognosis in intermediate coronary stenosis with FFR >0.75. To improve sensitivity, the cutoff value of FFR was raised to 0.8 in FAME and FAME II trials (6, 7) , and PCI for arteries with FFR ≤0.8 showed better prognosis compared with angiographically guided PCI and optimal medical therapy. Although there is a substantial grey zone between 0.75 and 0.8, FFR ≤0.75 can be assumed with a certainty of 99% that this lesion in responsible for coronary ischemia and FFR >0.80 gives only 5% chance that inducible ischemia is present (15) .
Based on the prognostic values, FFR has now become a gold standard of functionally significant stenosis triggering PCI. It was initially introduced as an invasive surrogate marker of relative severity of myocardial ischemia, and validated by comparison with PET-derived relative coronary flow reserve (CFR) (11) . Ironically, however, novel flowbased functional assessment parameters measured by PET should be validated by comparison with FFR as a reference test these days (16, 17) .
FFR vs MBF
PET-measured MBF has shown excellent agreement with that measured by microsphere injection and invasive activity measurement (18) (19) (20) (21) (22) . MBF can be measured by compartment modeling and estimation of rate constant values among tissue compartments ( Fig. 1) (23) . PET can measure MBF in an absolute volumetric term corrected for the myocardial mass (ml/min/g), which is not easily available in invasive measurements (24, 25) . Also, the measurement of MBF by PET is highly reproducible (26, 27) . Recently it was reported that even shorter acquisition time did not hamper the reproducibility of MBF measurement using 15 O water PET (28) . However, MBF values can vary according to which tracers or methods are used (29, 30) . So, it is recommended that the same tracer, analytical method and software be used Cp (t), arterial input function; C1 (t), 13 N ammonia activity in the freely diffusible compartment; C2 (t), metabolically trapped 13 On the other hand, MBF is affected by many extrinsic factors including age, sex, heart rate, blood pressure and myocardial oxygen consumption (40) . As a result, the normal reference or ischemic cutoff values of MBF and CFR substantially differ among studies (16, 31, 36, 41) , making it difficult to interpret in individual patients. Due to a poor distinction between epicardial stenosis and microvascular disease (42) , it is quite challenging to directly correlate MBF with a specific epicardial lesion. Even more, the widely used standardized myocardial segment model (43) even by rest-stress studies (68) . Also, the total radiation exposure from hybrid PET/CT did not reach 10 mSv without compromising image quality (69) . The development and evolution of PET, CT scanners and/or softwares will further reduce radiation exposure from hybrid imaging.
Conclusion
Despite the predominance of FFR in the management of stable CAD, FFR also has limitations. The flow-based and lesion-specific CAD assessment by hybrid imaging technique will play a key role in clinical practice, although it is not ready to be applied to individual patients so far. 
